+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Therapeutic Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
New

Therapeutic Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279931
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Therapeutic Radiopharmaceuticals Market is projected to reach USD 8.65 Billion in 2026. It is expected to continue growing at a CAGR of 11.81%, reaching USD 16.99 Billion by 2032.

Therapeutic Radiopharmaceuticals: Executive Overview

Therapeutic radiopharmaceuticals combine a radioactive isotope with a targeting molecule to deliver localized radiation to diseased tissue. The field is advancing through improved target identification, isotope production, radiochemistry, dosimetry, and clinical integration. Its development remains closely linked to evidence generation, regulatory requirements, specialized handling, and reliable access to nuclear medicine infrastructure.

Theranostics, Precision Targeting, and Supply Resilience Are Reshaping Care

The landscape is shifting toward theranostic pathways that pair diagnostic imaging with targeted radionuclide treatment. Progress in molecular biology is expanding the range of addressable targets, while better dosimetry and imaging support more individualized treatment planning. At the same time, isotope availability, reactor and accelerator capacity, transport constraints, workforce shortages, and specialized facility requirements remain central operational considerations. Adoption therefore depends not only on clinical efficacy but also on coordinated manufacturing, logistics, reimbursement, and referral networks.

Artificial Intelligence Strengthens Selection, Planning, and Evidence Generation

Artificial intelligence can support radiopharmaceutical development by improving image interpretation, target-expression assessment, patient selection, absorbed-dose estimation, treatment scheduling, and adverse-event monitoring. Machine-learning tools may also help integrate imaging, pathology, laboratory, and longitudinal outcomes data. Effective implementation requires representative datasets, transparent validation, clinician oversight, cybersecurity, and compliance with applicable medical-device and data-governance rules. AI is best viewed as an augmentation capability rather than a substitute for multidisciplinary clinical judgment.

Regional Insights: Infrastructure and Access Determine the Pace of Translation

North America benefits from established nuclear medicine capabilities, advanced oncology research, and active clinical development, while access and production capacity vary across jurisdictions. Europe has strong academic networks and regulatory coordination through the European Union, but faces differences in reimbursement, national adoption, and isotope logistics. Asia-Pacific combines sophisticated centers in countries such as Japan, South Korea, and Australia with rapidly expanding capabilities elsewhere, alongside varied infrastructure and regulatory maturity. Latin America is developing specialized services but must address uneven access, import dependence, and workforce capacity. The Middle East is investing in advanced healthcare infrastructure, with GCC countries often serving as regional hubs. Africa shows significant unmet need and emerging nuclear medicine capacity, but equipment, training, financing, and supply continuity remain important constraints.

Group Insights: Cooperation Can Reduce Fragmentation Across the Value Chain

ASEAN countries face diverse regulatory systems, healthcare capacities, and supply conditions, making regional training and coordinated standards valuable. BRICS members span substantial scientific and industrial capabilities but differ considerably in infrastructure, reimbursement, and access to isotopes. The European Union can benefit from shared scientific frameworks while managing national differences in health technology assessment and payment. G7 members generally possess strong research, regulatory, and clinical resources, with persistent challenges involving affordability, capacity, and equitable access. GCC countries can strengthen regional referral, logistics, and specialist networks. NATO members may benefit from resilient critical-supply planning and cross-border preparedness, although therapeutic radiopharmaceutical policy remains primarily a healthcare matter.

Country Insights: National Capabilities Shape Clinical Translation

The United States and Canada combine advanced oncology research with specialized nuclear medicine services, while access, reimbursement, and production resilience remain practical considerations. Germany, France, Italy, Spain, and the United Kingdom have established clinical and regulatory capabilities, but adoption differs according to national payment systems, health technology assessment, and service organization. Australia and Japan have mature nuclear medicine expertise, with geography and supply continuity influencing access. South Korea is strengthening precision oncology and radiopharmaceutical capabilities. China and India are expanding research, manufacturing, and clinical capacity, while regional variation remains significant. Brazil and Mexico are developing specialized services amid uneven infrastructure and import requirements. Russia retains nuclear science and isotope capabilities, while clinical access and international supply relationships may affect implementation.

Priorities for Leaders: Build Integrated, Resilient, Evidence-Based Care Pathways

Industry leaders should align isotope sourcing, radiochemistry, quality systems, distribution, and treatment capacity before expanding clinical programs. They should generate evidence that connects target expression, dosimetry, patient-reported outcomes, survival, and long-term safety, while engaging regulators and payers early. Partnerships with hospitals, imaging providers, academic centers, and logistics specialists can improve referral and administration pathways. Leaders should also invest in workforce development, contingency supply plans, validated digital tools, and responsible AI governance. Access strategies should account for regional disparities through hub-and-spoke services, standardized protocols, and transparent patient-selection criteria.

Methodology: Evidence-Led Synthesis of Clinical, Operational, and Policy Factors

This executive summary uses the supplied market definition and requested geographic groupings as an organizing framework. It synthesizes established themes in therapeutic radiopharmaceuticals, including clinical science, theranostics, isotope production, radiochemistry, infrastructure, regulation, reimbursement, logistics, workforce, and artificial intelligence. Regional, group, and country observations are qualitative and are intended to identify structural conditions rather than quantify market performance. No market estimates, shares, forecasts, or company-specific claims are included.

Conclusion: Coordinated Capability Is Essential for Sustainable Patient Access

Therapeutic radiopharmaceuticals are progressing through the convergence of molecular targeting, nuclear medicine, oncology, imaging, and precision treatment planning. The strongest outcomes will depend on more than scientific innovation: dependable isotope supply, specialized expertise, validated evidence, appropriate payment, and safe operational delivery are equally important. Stakeholders that coordinate these elements while using AI responsibly and addressing regional access gaps will be better positioned to translate clinical advances into durable patient benefit.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Therapeutic Radiopharmaceuticals Market, by Isotope Type
7.1. Introduction
7.2. Lutetium-177
7.3. Yttrium-90
7.4. Radium-223
7.5. Iodine-131
7.6. Actinium-225
8. Therapeutic Radiopharmaceuticals Market, by Radiation Type
8.1. Introduction
8.2. Alpha Emitters
8.3. Beta Emitters
8.4. Auger Electron Emitters
9. Therapeutic Radiopharmaceuticals Market, by Molecule Type
9.1. Introduction
9.2. Peptide-Based Radiopharmaceuticals
9.3. Small Molecule Radiopharmaceuticals
9.4. Monoclonal Antibody-Based Radiopharmaceuticals
9.5. Radioligand-Based Radiopharmaceuticals
10. Therapeutic Radiopharmaceuticals Market, by Route of Administration
10.1. Introduction
10.2. Oral
10.3. Parenteral
10.3.1. Intravenous (IV)
10.3.2. Intra-Arterial
11. Therapeutic Radiopharmaceuticals Market, by Indication area
11.1. Introduction
11.2. Oncology
11.2.1. Prostate Cancer
11.2.2. Neuroendocrine Tumors
11.2.3. Liver Cancer
11.2.4. Breast Cancer
11.2.5. Lung Cancer
11.2.6. Pancreatic Cancer
11.3. Non-oncology
12. Therapeutic Radiopharmaceuticals Market, by End-User
12.1. Introduction
12.2. Hospitals & Clinics
12.3. Academic & Research Institutes
12.4. Cancer Centers
13. Therapeutic Radiopharmaceuticals Market, by Region
13.1. Introduction
13.2. Europe
13.3. Asia-Pacific
13.4. North America
13.5. Latin America
13.6. Middle East
13.7. Africa
14. Therapeutic Radiopharmaceuticals Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. European Union
14.5. BRICS
14.6. ASEAN
14.7. GCC
15. Therapeutic Radiopharmaceuticals Market, by Country
15.1. Introduction
15.2. United States
15.3. Germany
15.4. China
15.5. United Kingdom
15.6. France
15.7. Japan
15.8. India
15.9. Canada
15.10. South Korea
15.11. Italy
15.12. Australia
15.13. Spain
15.14. Russia
15.15. Brazil
15.16. Mexico
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Therapeutic Radiopharmaceuticals Market, Years Considered for the Study
FIGURE 2. Global Therapeutic Radiopharmaceuticals Market, Research Design
FIGURE 3. Global Therapeutic Radiopharmaceuticals Market, Research Framework
FIGURE 4. Global Therapeutic Radiopharmaceuticals Market, Data Triangulation
FIGURE 5. Global Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2025 vs 2032 (%)
FIGURE 7. Global Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2025 vs 2032 (%)
FIGURE 9. Global Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2025 vs 2032 (%)
FIGURE 11. Global Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 13. Global Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2025 vs 2032 (%)
FIGURE 15. Global Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Therapeutic Radiopharmaceuticals Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Therapeutic Radiopharmaceuticals Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Therapeutic Radiopharmaceuticals Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Therapeutic Radiopharmaceuticals Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Therapeutic Radiopharmaceuticals Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Therapeutic Radiopharmaceuticals Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Therapeutic Radiopharmaceuticals Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Therapeutic Radiopharmaceuticals Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Therapeutic Radiopharmaceuticals Market Segmentation & Coverage
TABLE 2. Global Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 3. Global Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 4. Global Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Lutetium-177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Yttrium-90 Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Yttrium-90 Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Yttrium-90 Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Radium-223 Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Radium-223 Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Radium-223 Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Iodine-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Iodine-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Iodine-131 Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Actinium-225 Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 20. Global Alpha Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Alpha Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Alpha Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Beta Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Beta Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Beta Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Auger Electron Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Auger Electron Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Auger Electron Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 30. Global Peptide-Based Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Peptide-Based Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Peptide-Based Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Small Molecule Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Small Molecule Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Small Molecule Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Monoclonal Antibody-Based Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Monoclonal Antibody-Based Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Monoclonal Antibody-Based Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Radioligand-Based Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Radioligand-Based Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Radioligand-Based Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 43. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Intravenous (IV) Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Intravenous (IV) Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Intravenous (IV) Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Intra-Arterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Intra-Arterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Intra-Arterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 56. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Neuroendocrine Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Neuroendocrine Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Neuroendocrine Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Pancreatic Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Pancreatic Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Pancreatic Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Non-oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Non-oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Non-oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 81. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Cancer Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Cancer Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Cancer Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Europe Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 93. Europe Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 94. Europe Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 95. Europe Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 96. Europe Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 97. Europe Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 98. Europe Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 99. Europe Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 109. North America Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. North America Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 111. North America Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 112. North America Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 113. North America Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 114. North America Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 115. North America Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 116. North America Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 117. North America Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 118. Latin America Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Latin America Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 120. Latin America Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 121. Latin America Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 122. Latin America Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 123. Latin America Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 124. Latin America Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 125. Latin America Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 126. Latin America Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 127. Middle East Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Middle East Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 129. Middle East Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 130. Middle East Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 131. Middle East Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 132. Middle East Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 133. Middle East Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 134. Middle East Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 135. Middle East Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 136. Africa Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Africa Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 138. Africa Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 139. Africa Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 140. Africa Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 141. Africa Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 142. Africa Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 143. Africa Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 144. Africa Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 145. Global Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. NATO Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. NATO Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 148. NATO Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 149. NATO Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 150. NATO Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 151. NATO Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 152. NATO Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 153. NATO Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 154. NATO Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 155. G7 Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. G7 Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 157. G7 Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 158. G7 Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 159. G7 Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 160. G7 Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 161. G7 Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 162. G7 Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 163. G7 Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 164. European Union Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. European Union Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 166. European Union Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 167. European Union Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 168. European Union Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 169. European Union Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 170. European Union Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 171. European Union Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 172. European Union Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. BRICS Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. BRICS Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 175. BRICS Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 176. BRICS Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 177. BRICS Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 178. BRICS Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 179. BRICS Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 180. BRICS Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 181. BRICS Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 182. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 184. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 185. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 186. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 187. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 188. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 189. ASEAN Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 190. ASEAN Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 191. GCC Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. GCC Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 193. GCC Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 194. GCC Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 195. GCC Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 196. GCC Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 197. GCC Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 198. GCC Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 199. GCC Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 200. Global Therapeutic Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 201. United States Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 202. United States Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 203. United States Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 204. United States Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 205. United States Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 206. United States Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 207. United States Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 208. United States Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 209. United States Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 210. Germany Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 211. Germany Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 212. Germany Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 213. Germany Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 214. Germany Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 215. Germany Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 216. Germany Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 217. Germany Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 218. Germany Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 219. China Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 220. China Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 221. China Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 222. China Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 223. China Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 224. China Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 225. China Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 226. China Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 227. China Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 228. United Kingdom Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 229. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 230. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 231. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 232. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 233. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 234. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 235. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 236. United Kingdom Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 237. France Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 238. France Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 239. France Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 240. France Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 241. France Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 242. France Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 243. France Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 244. France Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 245. France Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 246. Japan Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 247. Japan Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 248. Japan Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 249. Japan Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 250. Japan Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 251. Japan Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 252. Japan Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 253. Japan Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 254. Japan Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 255. India Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 256. India Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 257. India Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 258. India Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 259. India Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 260. India Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 261. India Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 262. India Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 263. India Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 264. Canada Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 265. Canada Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 266. Canada Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 267. Canada Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 268. Canada Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 269. Canada Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 270. Canada Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 271. Canada Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 272. Canada Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 273. South Korea Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 274. South Korea Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 275. South Korea Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 276. South Korea Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 277. South Korea Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 278. South Korea Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 279. South Korea Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 280. South Korea Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 281. South Korea Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 282. Italy Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 283. Italy Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 284. Italy Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 285. Italy Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 286. Italy Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 287. Italy Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 288. Italy Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 289. Italy Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 290. Italy Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 291. Australia Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 292. Australia Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 293. Australia Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 294. Australia Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 295. Australia Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 296. Australia Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 297. Australia Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 298. Australia Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 299. Australia Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 300. Spain Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 301. Spain Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 302. Spain Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 303. Spain Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 304. Spain Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 305. Spain Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 306. Spain Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 307. Spain Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 308. Spain Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 309. Russia Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 310. Russia Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 311. Russia Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 312. Russia Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 313. Russia Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 314. Russia Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 315. Russia Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 316. Russia Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 317. Russia Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 318. Brazil Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 319. Brazil Therapeutic Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 320. Brazil Therapeutic Radiopharmaceuticals Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 321. Brazil Therapeutic Radiopharmaceuticals Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 322. Brazil Therapeutic Radiopharmaceuticals Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 323. Brazil Therapeutic Radiopharmaceuticals Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 324. Brazil Therapeutic Radiopharmaceuticals Market Size, by Indication area, 2017-2032 (USD Million)
TABLE 325. Brazil Therapeutic Radiopharmaceuticals Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 326. Brazil Therapeutic Radiopharmaceuticals Market Size, by End-User, 2017-2032 (USD Million)
TABLE 327. Mexico Therapeutic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 328. Mexico Therap

Companies Mentioned

  • Novartis AG
  • Boston Scientific Corporation
  • Bayer AG
  • Sirtex Medical Pty Ltd
  • Curium Pharma
  • Eckert & Ziegler SE
  • Telix Pharmaceuticals Limited
  • Jubilant Pharma Limited
  • Acrotech Biopharma Inc.
  • Actinium Pharmaceuticals, Inc.
  • AdvanCell Isotopes Pty Ltd
  • Alpha-9 Oncology, Inc.
  • Ariceum Therapeutics GmbH
  • ARTBIO, Inc.
  • Bristol-Myers Squibb Company
  • Cardinal Health Technologies, LLC
  • China Isotope and Radiation Corporation
  • Clarity Pharmaceuticals Ltd
  • Eli Lilly and Company
  • GE HealthCare Technologies Inc.
  • Institute of Isotopes Co., Ltd.
  • Ionetix Corporation
  • Isotopia Molecular Imaging Ltd.
  • ITM Isotope Technologies Munich SE
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Nusano, Inc.
  • Orano Med SAS
  • PDRadiopharma Inc.
  • Perspective Therapeutics, Inc.
  • Plus Therapeutics, Inc.
  • RadioMedix, Inc.
  • Radiopharm Theranostics Limited
  • Ratio Therapeutics Inc.
  • SHINE Technologies, LLC

Related Topics

Related Reports

Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Radiopharmaceutical Therapy Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceutical Therapy Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Nuclear Radiopharmaceutical Market - Global Forecast 2026-2032 - Product Image

Nuclear Radiopharmaceutical Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.